Semaglutide 2.4mg (weekly)
| Market | Price | Source |
|---|---|---|
| US private payCash, no insurance | $968 / mo | Novo Nordisk WAC 2026, shortage-easing premium |
| International genericLicensed retail equivalent | $799 / mo | HSA Singapore licensed |
What it is
Injectable semaglutide is sold in the US as Ozempic for type 2 diabetes and Wegovy for weight management. Weekly subcutaneous injection at doses from 0.25mg to 2.4mg.
Why the spread exists
Injectable semaglutide has the second-widest US private-pay spread in our index after tirzepatide. Patent protection through 2031, single manufacturer, and supply constraints during 2024-2026 elevated US list prices. International pricing reflects country-tier negotiation.
Brand vs generic
No generic semaglutide exists. All listings are brand Ozempic or Wegovy at different country prices. Compounded semaglutide from US 503A pharmacies is a separate contested category we do not include.
Regulatory status
Semaglutide is prescription-only in every jurisdiction we track. Cold-chain handling required. Not a controlled substance.
International generic price is the median of at least three independent licensed retail listings. We do not endorse any single vendor; we treat each as a price observation. Listed below for transparency.
- PHARMAX retail listing
- HSA Singapore licensed retail
- Sun Pharma export portal
Publisher's note. Rx Price Tracker is funded by PHARMAX, one of the international pharmacies whose prices we publish on this page. PHARMAX does not control which molecules we cover, which competitors we include, or which corrections we issue. Every price observation links to its source URL and capture date. The data is reproducible. We track the gap because pricing transparency works in any direction.